INHIBITION OF PLATELET ACTIVATION BY THE NOVEL THROMBOXANE RECEPTOR ANTAGONIST BM 13.505

被引：0
|
作者：
PATSCHEKE, H
STEGMEIER, K
HORNBERGER, W
STAIGER, C
NEUGEBAUER, G
机构：
[1] UNIV HEIDELBERG,KLINIKUM MANNHEIM,INST CLIN CHEM,D-6800 MANNHEIM 1,FED REP GER
[2] BOEHRINGER MANNHEIM GMBH,DEPT MED RES,D-6800 MANNHEIM 31,FED REP GER
来源：
THROMBOSIS AND HAEMOSTASIS | 1987年 / 58卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [31] QUANTITATION OF DRUG LEVELS AND PLATELET RECEPTOR BLOCKADE CAUSED BY A THROMBOXANE ANTAGONIST
    FRIEDHOFF, LT
    MANNING, J
    FUNKE, PT
    IVASHKIV, E
    TU, J
    COOPER, W
    WILLARD, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (06) : 634 - 642
  • [32] INHIBITION OF FLUID STRESS-INDUCED PLATELET ACTIVATION BY THE NOVEL IIB/IIIA RECEPTOR ANTAGONIST SC-49992
    GIORGIO, TD
    FEIGEN, LP
    FASEB JOURNAL, 1992, 6 (04): : A1598 - A1598
  • [33] Effects of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, on osteogenic sarcoma cell-induced platelet aggregation.
    de Leval, X
    David, JL
    Neven, P
    Benoit, V
    Pirotte, B
    Merville, MP
    Bours, V
    Dogné, JM
    BLOOD, 2001, 98 (11) : 43B - 43B
  • [34] BM-13 177 - A NOVEL THROMBOXANE A2-ANTAGONIST WITH ANTITHROMBOTIC ACTION
    KOCH, H
    PHARMACY INTERNATIONAL, 1985, 6 (10): : 245 - 246
  • [35] ANTIARRHYTHMIC EFFECTS OF THE THROMBOXANE ANTAGONIST BM-13177
    WAINWRIGHT, CL
    PARRATT, JR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 133 (03) : 257 - 264
  • [36] Inhibition of thromboxane mediated platelet aggregation by GPIb receptor blockade
    Kerrigan, S
    Douglas, I
    Fitzgerald, D
    Cox, D
    THROMBOSIS AND HAEMOSTASIS, 1999, : 634 - 634
  • [37] CHARACTERIZATION OF PLATELET THROMBOXANE-A2 PROSTAGLANDIN-H-2 RECEPTOR BY A NOVEL THROMBOXANE RECEPTOR ANTAGONIST, [H-3]S-145
    HANASAKI, K
    NAGASAKI, T
    ARITA, H
    BIOCHEMICAL PHARMACOLOGY, 1989, 38 (12) : 2007 - 2017
  • [38] Reply to “Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin”
    Lidija Covic
    Suzanne Jacques
    Athan Kuliopulos
    Nature Medicine, 2003, 9 : 1447 - 1448
  • [39] BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane A2 receptors.
    Hanson, J
    Rolin, S
    de Leval, X
    Neven, P
    de Leval, L
    Masereel, B
    Pirotte, B
    Dogné, JM
    BLOOD, 2003, 102 (11) : 813A - 814A
  • [40] A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models
    Huang, Shiu-Wen
    Kuo, Heng-Lan
    Hsu, Ming-Tsung
    Tseng, Yufeng Jane
    Lin, Shu-Wha
    Kuo, Sheng-Chu
    Peng, Hui-Chin
    Lien, Jin-Cherng
    Huang, Tur-Fu
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (02) : 285 - 299
12345